NEW YORK (GenomeWeb News) – Exiqon and MultiD Analyses today announced a development and distribution agreement incorporating a specifically adapted version of MultiD's GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform.
As a result of the deal, Exiqon will now be able to sell a fully compatible and comprehensive data analysis solution to complete its microRNA qPCR offering, the company said in a statement.
GenEx software is used to process and analyze qPCR data, and its capabilities include the selection and validation of reference genes, data pre-processing, and advanced statistical methods for the analysis of qPCR experiments.
The newly designed software for Exiqon's new qPCR platform — called the miRCURY LNA Universal RT microRNA PCR system — includes a plate design module which enables customers to design their qPCR experiments in silico and "generate templates for import into their real-time PCR instrument," Mikael Kubista, chairman of MultiD, said in a statement.
Based in Vedbaek, Denmark, Exiqon develops tools for microRNA research. MultiD is headquartered in Göteborg, Sweden, and develops software for qPCR analysis.
Financial terms of the agreement were not disclosed.